Sleep and circadian rhythms in Parkinson's disease and preclinical models

J Hunt, EJ Coulson, R Rajnarayanan, H Oster… - Molecular …, 2022 - Springer
The use of animals as models of human physiology is, and has been for many years, an
indispensable tool for understanding the mechanisms of human disease. In Parkinson's …

Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases

L Subedi, BP Gaire - Pharmacological research, 2021 - Elsevier
Tanshinones, lipophilic diterpenes isolated from the rhizome of Salvia miltiorrhiza, have
diverse pharmacological activities against human ailments including neurological diseases …

Diagnosis and management of Parkinson's disease

A Tarakad, J Jankovic - Seminars in neurology, 2017 - thieme-connect.com
Despite numerous efforts to identify specific and sensitive biomarkers, the diagnosis of
Parkinson's disease (PD) is still based on clinical criteria that include the presence of a …

mTOR-related brain dysfunctions in neuropsychiatric disorders

L Ryskalin, F Limanaqi, A Frati, CL Busceti… - International journal of …, 2018 - mdpi.com
The mammalian target of rapamycin (mTOR) is an ubiquitously expressed serine-threonine
kinase, which senses and integrates several intracellular and environmental cues to …

[PDF][PDF] Psychiatric manifestation in patients with Parkinson's disease

JW Han, YD Ahn, WS Kim, CM Shin… - Journal of Korean …, 2018 - synapse.koreamed.org
Parkinson's disease (PD) is the second most common neurodegenerative disorder.
Although its major manifestation is motor symptoms, resulting from the loss of dopaminergic …

[HTML][HTML] Neuropsychiatric symptoms in spinocerebellar ataxias and Friedreich ataxia

S Karamazovova, V Matuskova, Z Ismail… - … & Biobehavioral Reviews, 2023 - Elsevier
Apart from its role in motor coordination, the importance of the cerebellum in cognitive and
affective processes has been recognized in the past few decades. Spinocerebellar ataxias …

Emergent functional network effects in Parkinson disease

C Gratton, JM Koller, W Shannon, DJ Greene… - Cerebral …, 2019 - academic.oup.com
The hallmark pathology underlying Parkinson disease (PD) is progressive synucleinopathy,
beginning in caudal brainstem that later spreads rostrally. However, the primarily subcortical …

Stigma, self-compassion, and psychological distress among people with Parkinson's

FJR Eccles, N Sowter, T Spokes, N Zarotti… - Disability and …, 2023 - Taylor & Francis
Abstract Purpose People with Parkinson's disease (hereafter Parkinson's) can experience
stigma through the attitudes and actions of others (enacted stigma) and through anticipation …

Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease

GC do Nascimento, DP Ferrari, FS Guimaraes… - …, 2020 - Elsevier
Medications that improve pain threshold can be useful in the pharmacotherapy of
Parkinson's disease (PD). Pain is a prevalent PD's non-motor symptom with a higher …

Transcranial direct current stimulation combined with cognitive training for the treatment of Parkinson disease: a randomized, placebo-controlled study

R Manenti, MS Cotelli, C Cobelli, E Gobbi, M Brambilla… - Brain Stimulation, 2018 - Elsevier
Background A number of non-motor symptoms occurs in Parkinson Disease (PD), cognitive
decline and mood disturbances representing the most prevalent. Recent studies reported …